生命科学资讯
生物技术与制药领域的最新动态
Guardant hits the road with colon cancer blood test
Lonza to Establish GCC in Hyderabad to Strengthen Telangana’s Life Sciences Ecosystem? - Analytics India Magazine
Swiss pharma group Lonza to set up new GCC in Hyderabad - BusinessLine
Global life sciences hub: Lonza picks Hyderabad for new Global Capability Centre - NewsMeter
10x genomics CEO Saxonov sells $367,096 in shares - Investing.com
Cresset资产管理公司增持赛默飞世尔科技股份$TMO - MarketBeat
Cresset Asset Management LLC Increases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
ARK Investment Management Boosts Stake in Illumina - National Today
ARK Investment Management LLC Has $139.41 Million Position in Illumina, Inc. $ILMN - MarketBeat
10x Genomics $TXG Shares Sold by ARK Investment Management LLC - MarketBeat
罗氏与利益相关者呼吁非洲将健康视为经济投资——真实新闻杂志
Roche, stakeholders urge Africa to treat health as economic investment - Realnews Magazine
Thermo Fisher在乌普萨拉新建分销与标签中心，扩展免疫诊断业务 - BioSpectrum Asia
Thermo Fisher expands immunodiagnostics operations with new distribution and labeling centre in Uppsala - BioSpectrum Asia
Thermo Fisher推出DXR3 SmartRaman+，实现无损在线拉曼质量控制——研发世界
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC - R&D World
高中班级在安捷伦科技公司度过一天——海岸视野新闻
High school class spends a day at Agilent Technologies - Coastal View News
Octane Medical Group 签署协议收购 Lonza 个性化医疗业务 - TMX Newsfile
Octane Medical Group Signs Agreement to Acquire Lonza's Personalized Medicine Business - TMX Newsfile
沃特世公司2026年股票回顾：增长与盈利能力隐忧——新闻与数据——IndexBox
Waters Corporation Stock Review 2026: Growth and Profitability Concerns - News and Statistics - IndexBox
Thermo Fisher推出显色培养基，加速念珠菌感染鉴定进程 - R&D World
Thermo Fisher introduces chromogenic culture media for faster identification of Candida infections - R&D World
10x Genomics (TXG) CEO出售股份并赠予股票 - 股票泰坦
10x Genomics (TXG) CEO sells shares and makes stock gift - Stock Titan
罗氏斥资4.8亿美元注入韩国生物制药产业，构建全球临床试验"生态系统"。
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
辉瑞肿瘤研发战略：杰夫·莱戈斯谈速度、广度与创新组合
Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations